We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
+$29.1B
Cap. Flow
-$16.6B
Cap. Flow %
-3.43%
Top 10 Hldgs %
36.47%
Holding
15,826
New
1,205
Increased
5,575
Reduced
7,223
Closed
1,563

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$545M
2
DXCM icon
DexCom
DXCM
+$457M
3
T icon
AT&T
T
+$431M
4
PANW icon
Palo Alto Networks
PANW
+$416M
5
HUM icon
Humana
HUM
+$394M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Healthcare 2.92%
3 Consumer Discretionary 1.99%
4 Financials 1.93%
5 Industrials 1.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CUENW
13976
DELISTED
Cuentas, Inc. Warrant
CUENW
$733 ﹤0.01%
+19,296
New +$1.24K
CSWC icon
13977
Capital Southwest
CSWC
$1.61B
$730 ﹤0.01%
37
-115
-76% -$2.12K
TSHA icon
13978
PUT
Taysha Gene Therapies
TSHA
$1.92B
$727 ﹤0.01%
1,100
-100
-8% -$72
PVLA
13979
PUT
Palvella Therapeutics
PVLA
$2.26B
$712 ﹤0.01%
54
-12
-18% -$728
LCTX icon
13980
PUT
Lineage Cell Therapeutics
LCTX
$268M
$705 ﹤0.01%
500
RDHL
13981
CALL
Redhill Biopharma
RDHL
$3.59M
$699 ﹤0.01%
+23
New +$1.33K
PFTAW
13982
DELISTED
Perception Capital Corp. III Warrant
PFTAW
$696 ﹤0.01%
+34,822
New +$2.65K
GAIA icon
13983
CALL
Gaia
GAIA
$33.3M
$693 ﹤0.01%
300
-800
-73% -$2.22K
GTACW
13984
DELISTED
Global Technology Acquisition Corp. I Warrant
GTACW
$687 ﹤0.01%
+11,330
New +$675
GTIM icon
13985
CALL
Good Times Restaurants
GTIM
$15.8M
$680 ﹤0.01%
200
-5,200
-96% -$14.8K
CMRAW
13986
DELISTED
Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027
CMRAW
$676 ﹤0.01%
22,769
-6,211
-21% -$207
SAMAW
13987
DELISTED
Schultze Special Purpose Acquisition Corp. II Warrant
SAMAW
$660 ﹤0.01%
16,100
+1,088
+7% +$67
PORT.WS
13988
DELISTED
Southport Acquisition Corporation Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50
PORT.WS
$659 ﹤0.01%
+16,478
New +$710
OVID icon
13989
PUT
Ovid Therapeutics
OVID
$523M
$656 ﹤0.01%
200
ADCT icon
13990
CALL
ADC Therapeutics
ADCT
$134M
$645 ﹤0.01%
300
-400
-57% -$899
BEST
13991
PUT
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$639 ﹤0.01%
+300
New +$777
AP icon
13992
PUT
Ampco-Pittsburgh
AP
$190M
$636 ﹤0.01%
200
-4,500
-96% -$13.4K
TVGNW icon
13993
Tevogen Inc. Warrant
TVGNW
$911K
$633 ﹤0.01%
15,358
-4,212
-22% -$227
ALLT icon
13994
CALL
Allot
ALLT
$377M
$632 ﹤0.01%
200
-300
-60% -$845
FTI icon
13995
TechnipFMC
FTI
$29.5B
$632 ﹤0.01%
38
-289,279
-100% -$4.08M
CPAAW
13996
DELISTED
Conyers Park III Acquisition Corp. Warrants
CPAAW
$630 ﹤0.01%
12,610
-302,235
-96% -$39.9K
IPVF.WS
13997
DELISTED
InterPrivate III Financial Partners Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
IPVF.WS
$617 ﹤0.01%
+12,619
New +$546
GALT icon
13998
Galectin Therapeutics
GALT
$356M
$616 ﹤0.01%
428
-850
-67% -$1.44K
NWG icon
13999
PUT
NatWest
NWG
$76.9B
$612 ﹤0.01%
100
TRCA.WS
14000
DELISTED
Twin Ridge Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
TRCA.WS
$610 ﹤0.01%
+11,160
New +$708

Similar funds

Citadel Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Citadel Advisors held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Citadel Advisors withdrew a net $16.6B in Q2 2023, closing 1,563 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Citadel Advisors opened a new position in BILL Holdings worth $222M.

  • Citadel Advisors's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
  • Citadel Advisors added most to Microsoft in Q2 2023, an estimated $640M increase.
  • Citadel Advisors's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
  • Citadel Advisors fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
  • Citadel Advisors's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
  • Citadel Advisors opened 1,205 new positions and closed 1,563 in Q2 2023.
  • Citadel Advisors's portfolio value rose 6.4% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.